Meperidine Hydrochloride Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Meperidine Hydrochloride Tablets contain NLT 95.0% and NMT 105.0% of the labeled amount of meperidine hydrochloride (C15H21NO2 · HCl).
2 IDENTIFICATION
A. Identification—Organic Nitrogenous Bases 〈181〉
Sample solution: Transfer an amount nominally equivalent to about 50 mg of meperidine hydrochloride from powdered Tablets to a separator, add 10 mL of water, and shake. Add 5 mL of saturated sodium chloride solution and 1 mL of sodium hydroxide solution (1 in 25). Extract with three 20-mL portions of chloroform, filtering the extracts through cotton overlaid with anhydrous sodium sulfate. Evaporate the chloroform on a steam bath, and dissolve the residue in 4 mL of carbon disulfide.
Standard solution: In a second separator, proceed as directed in the Sample solution, using 50 mg of USP Meperidine Hydrochloride RS.
Analysis: Proceed as directed in the chapter, beginning with “Determine the absorption spectra”.
Acceptance criteria: Meet the requirements
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Procedure
Solution A: Transfer about 6.8 g of monobasic potassium phosphate to a 1000-mL volumetric flask. Dissolve in and dilute with water to volume. Add 10 mL of triethylamine, and mix. Adjust with phosphoric acid to a pH of 7.0, and filter.
Mobile phase: Acetonitrile and Solution A (550:450), filtered and degassed
Standard stock solution: 0.6 mg/mL of USP Meperidine Hydrochloride RS in water
Standard solution: 0.12 mg/mL of USP Meperidine Hydrochloride RS from the Standard stock solution in Mobile phase
Sample stock solution: Transfer an amount nominally equivalent to about 60 mg of meperidine hydrochloride from NLT 20 finely powdered
Tablets to a 100-mL volumetric flask. Add about 70 mL of Mobile phase, and sonicate for 10 min with occasional shaking. Shake by mechanical means for about 30 min, dilute with Mobile phase to volume, mix, and filter.
Sample solution: Nominally equivalent to 0.12 mg/mL of meperidine hydrochloride in Mobile phase from the Sample stock solution
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 230 nm
Column: 3.9-mm × 30-cm; packing L1
Flow rate: 1 mL/min
Injection volume: 20 μL
System suitability
Sample: Standard solution
Suitability requirements
Column efficiency: NLT 2000 theoretical plates
Tailing factor: NMT 2 for the meperidine peak
Relative standard deviation: NMT 2%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of meperidine hydrochloride (C15H21NO2 · HCl) in the portion of Tablets taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of meperidine from the Sample solution
rS = peak response of meperidine from the Standard solution
CS = concentration of USP Meperidine Hydrochloride RS in the Standard solution (mg/mL)
CU = nominal concentration of meperidine hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: 95.0%–105.0%
4 PERFORMANCE TESTS
Dissolution 〈711〉
Medium: Water; 500 mL
Apparatus 1: 100 rpm
Time: 45 min
Standard solution: A known concentration of USP Meperidine Hydrochloride RS in Medium
Sample solution: Filter portions of the solution under test, and suitably dilute with Medium, if necessary.
Chromatographic system and System suitability: Proceed as directed in the Assay.
Analysis: Determine the labeled amount of meperidine hydrochloride (C15H21NO2 · HCl) dissolved by comparing the peak response of meperidine from the Sample solution with that from the Standard solution.
Tolerances: NLT 75% (Q) of the labeled amount of meperidine hydrochloride (C15H21NO2 · HCl) is dissolved.
Uniformity of Dosage Units 〈905〉: Meet the requirements
5 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed, light-resistant containers.
USP Reference Standards 〈11〉
USP Meperidine Hydrochloride RS

